. 2006 Sep 30;21(3):159–164. doi: 10.3904/kjim.2006.21.3.159

Table 5.

Previous reports of salvage regimens for refractory/relapsed non-Hodgkin's lymphoma

graphic file with name kjim-21-159-i005.jpg

CR, complete remission; OR, overall response; HDARAC, high-dose ara-C; mitox., mitoxantrone; DHAP, dexamethasone; high-dose ara-C, cisplatin; EPOCH, etoposide, prednisolone, vincristine, cyclophosphamide and doxorubicin; ESHAP, etoposide, solumedrol, high-dose ara-C and cisplatin; MINE-ESHAP, mesna, ifosphamide, mitoxantrone (novantrone) and etoposide, followed by ESHAP; TRD, treatment-related death; OS, median overall survival.